* 中国先声药业2096.HK周三早盘涨幅扩大至2.8%。
* 该公司此前公告称，从香港康乃德生物医药引进的乐德奇拜单抗新药上市申请获国家药品监督管理局受理，用于治疗成人及青少年特应性皮炎。
* 先声药业今年迄今劲涨51.5%，同期恒生指数.HSI大幅上扬19.6%。
* 恒生综合行业指数 - 医疗保健业.HSCIH盘中一度升2.3%。（完）
更多股市简讯请点选CN-CMN-HOT
(发稿 徐凯文；审校 林高丽)
((kaiwen.xu@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.